SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Trade/Invest with Options Jerry a Point & Figure Chartist -- Ignore unavailable to you. Want to Upgrade?

To: Hans who wrote (2906)7/25/2001 10:38:23 AM
From: Frederick Langford  Respond to of 5893
 
MYGN held 40 till yesterday. I think it's oversold.

Fred



To: Hans who wrote (2906)7/25/2001 11:30:00 AM
From: Jerry Olson  Respond to of 5893
 
JUST IN FOR A SHORT LUNCH

WATCH ALL LONGS THIS AFTERNOON, WE DO HAVE CYCLE LOWS COMING IN TODAY...

TIGHT STOPS...



To: Hans who wrote (2906)7/25/2001 11:42:07 AM
From: Frederick Langford  Respond to of 5893
 
11:29 ET Myriad Genetics (MYGN) 39.75 +1.24: -- Technical -- This one is oversold on both the near-term and intermediate-term indicators. Exhibiting relative strength today on the back of relative outperformance by the biotech sector (BTK +2.1%). Has little in the way of overhead until a recent area of very minor congestion around 41.70 with a secondary resistance level around 43.50. Has very minor support at 39.10 with secondary support at 38.50.

Fred


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News